![](/img/cover-not-exists.png)
Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study
Westermann, J, Flörcken, A, Willimsky, G, van Lessen, A, Kopp, J, Takvorian, A, Jöhrens, K, Lukowsky, A, Schönemann, C, Sawitzki, BVolume:
18
Year:
2010
Language:
english
Pages:
10
DOI:
10.1038/gt.2010.143
File:
PDF, 715 KB
english, 2010